What's Going On With Palantir Technologies Today?
What's Going On With Palantir Technologies Today?
Palantir Technologies Inc. (NYSE:PLTR) shares are trading lower in the premarket session on Thursday.
Palantir Technologies Inc.（紐約證券交易所代碼：PLTR）股價在週四的盤前交易中走低。
The AI giant inked a multi-year strategic partnership with clinical research organization Parexel to enhance and accelerate the delivery of safe and effective clinical trials for the world's biopharmaceutical customers.
這家人工智能巨頭與臨床研究組織Parexel簽署了多年戰略合作伙伴關係，以加強和加快爲全球生物製藥客戶提供安全有效的臨床試驗。
Under the collaboration, Parexel will leverage Palantir's Foundry and Artificial Intelligence Platform (AIP) to boost its clinical data platform.
根據合作，Parexel將利用Palantir的鑄造和人工智能平台（AIP）來提升其臨床數據平台。
The platform is focused on driving clinical trial efficiency while maintaining the highest level of safety and regulatory rigor.
該平台專注於提高臨床試驗效率，同時保持最高水平的安全性和監管嚴格性。
"Leveraging our internal Parexel expertise and our strategic partnership with Palantir, we have novel solutions already in use or in various stages of development that demonstrate our commitment to be a fully digital CRO," said Jonathan Shough, Chief Information Officer for Parexel.
Parexel首席信息官喬納森·肖夫表示：“利用我們在Parexel的內部專業知識以及與Palantir的戰略合作伙伴關係，我們已經在使用或處於不同開發階段的新型解決方案，這表明了我們對成爲完全數字化的CRO的承諾。”
Parexel is the first CRO working with Palantir in this capacity, building on the companies' existing collaboration over the past year, according to a press release.
根據一份新聞稿，Parexel是第一家以此身份與Palantir合作的CRO，這是兩家公司在過去一年的現有合作基礎上。
Parexel Precision Pathway is an end-to-end operational approach that prioritizes the timely delivery of clean data while driving efficiency, quality and predictability.
Parexel Precision Pathway是一種端到端的運營方法，它優先考慮及時交付乾淨的數據，同時提高效率、質量和可預測性。
"The company will significantly accelerate its business by untapping the value of data via an ontology constructed within Palantir Foundry and connecting it to the immense power of generative AI in AIP," said Dr. Lalarukh Haris Shaikh, Executive, Life Sciences at Palantir.
Palantir生命科學高管拉拉魯克·哈里斯·謝赫博士表示：“該公司將通過Palantir Foundry內部構建的本體論挖掘數據的價值，並將其與AIP中生成式人工智能的巨大力量聯繫起來，從而顯著加快其業務發展。”
Supported by Palantir's software, Parexel's clinical data platform provides an integrated digital environment to hyper-automate manual processes, promote data discoverability, distill insights from historical trials, and streamline coordination among scientific and operational teams and their partners.
在Palantir軟件的支持下，Parexel的臨床數據平台提供了一個集成的數字環境，可實現手動流程的超自動化，提高數據的可發現性，從歷史試驗中提取見解，並簡化科學和運營團隊及其合作伙伴之間的協調。
Palantir is set to report its first-quarter financial results on May 6 after the market close. According to estimates from Benzinga Pro, analysts expect the company to report earnings of 8 cents per share and quarterly revenue of $625.33 million.
Palantir定於5月6日收盤後公佈其第一季度財務業績。根據Benzinga Pro的估計，分析師預計該公司將公佈每股收益8美分，季度收入爲6.2533億美元。
Price Action: PLTR shares are trading lower by 1.07% to $21.36 premarket at last check Thursday.
價格走勢：週四最後一次盤前檢查時，PLTR股價下跌1.07％，至21.36美元。
Photo via Shutterstock
照片來自 Shutterstock
譯文內容由第三人軟體翻譯。